FI870501A0 - Method for producing an antigenic peptide or antigenic protein derived from the melanoma-associated antigen p97 and useful recombinant viruses, recombinant vectors and host cells. - Google Patents
Method for producing an antigenic peptide or antigenic protein derived from the melanoma-associated antigen p97 and useful recombinant viruses, recombinant vectors and host cells.Info
- Publication number
- FI870501A0 FI870501A0 FI870501A FI870501A FI870501A0 FI 870501 A0 FI870501 A0 FI 870501A0 FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 870501 A0 FI870501 A0 FI 870501A0
- Authority
- FI
- Finland
- Prior art keywords
- melanoma
- producing
- antigenic
- host cells
- associated antigen
- Prior art date
Links
- 230000000890 antigenic effect Effects 0.000 title 2
- 101000798109 Homo sapiens Melanotransferrin Proteins 0.000 title 1
- 102100032239 Melanotransferrin Human genes 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82731386A | 1986-02-07 | 1986-02-07 | |
| US82731386 | 1986-02-07 | ||
| US07/007,230 US5262177A (en) | 1986-02-07 | 1987-01-27 | Recombinant viruses encoding the human melanoma-associated antigen |
| US723087 | 1996-10-01 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI870501A0 true FI870501A0 (en) | 1987-02-06 |
| FI870501A FI870501A (en) | 1987-08-08 |
| FI94836B FI94836B (en) | 1995-07-31 |
| FI94836C FI94836C (en) | 1995-11-10 |
Family
ID=26676698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI870501A FI94836C (en) | 1986-02-07 | 1987-02-06 | A method for producing an antigenic cognate peptide or protein of the melanoma-associated p97 antigen, and recombinant viruses, recombinant vectors and host cells useful therein |
Country Status (18)
| Country | Link |
|---|---|
| JP (3) | JP2664673B2 (en) |
| BE (1) | BE1000175A3 (en) |
| CH (1) | CH675424A5 (en) |
| DE (1) | DE3703702C2 (en) |
| DK (1) | DK63287A (en) |
| ES (2) | ES2012815A6 (en) |
| FI (1) | FI94836C (en) |
| GR (1) | GR870195B (en) |
| HU (1) | HU209144B (en) |
| IE (1) | IE59597B1 (en) |
| IT (1) | IT1222359B (en) |
| MX (1) | MX9203574A (en) |
| NL (1) | NL8700285A (en) |
| NO (1) | NO178931C (en) |
| NZ (1) | NZ219192A (en) |
| OA (1) | OA08478A (en) |
| PT (1) | PT84255B (en) |
| SE (2) | SE506024C2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19821925A1 (en) * | 1998-05-15 | 1999-11-18 | Roehnisch Tim | Bacteriophage expression system for production of composition for induction of tumor specific responses |
| JP4414023B2 (en) * | 1999-08-05 | 2010-02-10 | オリエンタル酵母工業株式会社 | Method and reagent for measuring arthritis-related melanotransferrin |
| JP4708027B2 (en) * | 2002-10-01 | 2011-06-22 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Anti-cancer compositions and anti-infective disease compositions and methods of using them |
| US8207314B2 (en) * | 2003-05-16 | 2012-06-26 | Sanofi Pasteur Limited | Tumor antigens for prevention and/or treatment of cancer |
-
1987
- 1987-02-05 NZ NZ219192A patent/NZ219192A/en unknown
- 1987-02-06 DE DE3703702A patent/DE3703702C2/en not_active Expired - Fee Related
- 1987-02-06 BE BE8700094A patent/BE1000175A3/en not_active IP Right Cessation
- 1987-02-06 HU HU87472A patent/HU209144B/en not_active IP Right Cessation
- 1987-02-06 FI FI870501A patent/FI94836C/en not_active IP Right Cessation
- 1987-02-06 NL NL8700285A patent/NL8700285A/en not_active Application Discontinuation
- 1987-02-06 GR GR870195A patent/GR870195B/en unknown
- 1987-02-06 IE IE31987A patent/IE59597B1/en not_active IP Right Cessation
- 1987-02-06 DK DK063287A patent/DK63287A/en not_active Application Discontinuation
- 1987-02-06 JP JP62026191A patent/JP2664673B2/en not_active Expired - Lifetime
- 1987-02-06 PT PT84255A patent/PT84255B/en not_active IP Right Cessation
- 1987-02-06 OA OA59065A patent/OA08478A/en unknown
- 1987-02-06 IT IT19291/87A patent/IT1222359B/en active
- 1987-02-06 ES ES8700288A patent/ES2012815A6/en not_active Expired - Fee Related
- 1987-02-06 NO NO870475A patent/NO178931C/en unknown
- 1987-02-06 SE SE8700466A patent/SE506024C2/en not_active IP Right Cessation
- 1987-02-09 CH CH471/87A patent/CH675424A5/en not_active IP Right Cessation
-
1989
- 1989-06-15 ES ES8902106A patent/ES2017258A6/en not_active Expired - Fee Related
-
1992
- 1992-06-26 MX MX9203574A patent/MX9203574A/en not_active Application Discontinuation
- 1992-10-07 SE SE9202934A patent/SE9202934D0/en unknown
-
1996
- 1996-03-12 JP JP8054929A patent/JPH08280390A/en active Pending
- 1996-03-12 JP JP8054928A patent/JPH09135692A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62294698A (en) | 1987-12-22 |
| FI94836B (en) | 1995-07-31 |
| MX9203574A (en) | 1992-07-01 |
| DE3703702A1 (en) | 1988-02-18 |
| JP2664673B2 (en) | 1997-10-15 |
| IE59597B1 (en) | 1994-03-09 |
| OA08478A (en) | 1988-07-29 |
| NO870475L (en) | 1987-08-10 |
| SE8700466D0 (en) | 1987-02-06 |
| SE8700466L (en) | 1987-08-08 |
| DK63287D0 (en) | 1987-02-06 |
| JPH09135692A (en) | 1997-05-27 |
| FI94836C (en) | 1995-11-10 |
| ES2017258A6 (en) | 1991-01-16 |
| NZ219192A (en) | 1991-10-25 |
| IE870319L (en) | 1987-08-07 |
| GR870195B (en) | 1987-06-10 |
| PT84255A (en) | 1987-03-01 |
| DK63287A (en) | 1987-08-08 |
| IT8719291A0 (en) | 1987-02-06 |
| NO870475D0 (en) | 1987-02-06 |
| NL8700285A (en) | 1987-09-01 |
| BE1000175A3 (en) | 1988-07-12 |
| HUT43107A (en) | 1987-09-28 |
| FI870501A (en) | 1987-08-08 |
| NO178931C (en) | 1996-07-03 |
| NO178931B (en) | 1996-03-25 |
| HU209144B (en) | 1994-03-28 |
| DE3703702C2 (en) | 1997-07-10 |
| JPH08280390A (en) | 1996-10-29 |
| IT1222359B (en) | 1990-09-05 |
| CH675424A5 (en) | 1990-09-28 |
| SE9202934D0 (en) | 1992-10-07 |
| ES2012815A6 (en) | 1990-04-16 |
| PT84255B (en) | 1989-11-30 |
| SE506024C2 (en) | 1997-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3583293D1 (en) | LYMPHADENOPATHY-ASSOCIATED SHELL ANTIGENS AND THEIR USE. | |
| NO870412L (en) | PEPTIDES. | |
| DK0757717T3 (en) | papillomavirus vaccines | |
| ES2002490A6 (en) | Vaccines and immunoassays for acquired immune deficiency syndrome | |
| AU2445888A (en) | Recombinant fowlpox virus, vectors for the expression of heterologous proteins and vaccines for poultry derived from this virus | |
| ATE97164T1 (en) | RECOMBINANT VACCINIA VIRUS MVA. | |
| NO912825L (en) | PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IM MUNOGENT PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS. | |
| AU4826493A (en) | Anti-feline immunodeficiency virus (fiv) vaccines | |
| FI864991A (en) | EXPRESSION AND DIAGNOSTIC ANVAENDNING AV PEPTIDER KODADE AV GAG-REGION VILKA PEPTIDER AER IMMUNOLOGICALLY REACTIVE WITH ANTICROPPAR AV LAV VIRUS. | |
| DK457687D0 (en) | ANTIGENIC ACTIVE PROTEINS AND PEPTIDES AND VACCINES AGAINST VIRUS FOR FELIN PERITONITIS (FIPV) CONTAINING SUCH PROTEIN OR PEPTIDES | |
| FI870501A0 (en) | Method for producing an antigenic peptide or antigenic protein derived from the melanoma-associated antigen p97 and useful recombinant viruses, recombinant vectors and host cells. | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| DK498387D0 (en) | Viral DNA SEQUENCE | |
| OA09653A (en) | Rubella peptides | |
| CA2088478A1 (en) | Cloning and expression of a rhoptry associated protein of p. falciparum | |
| FI90562C (en) | New Bacillus thuringiensis serovar. israelensis mutants, process for the preparation of spore-free, concentrated, mosquito-toxic protein preparations and their use | |
| ATE69056T1 (en) | TGF-POLYPEPTIDES, ANTIGENS OLIGOPEPTIDES DERIVED THEREOF, ANTIBODIES OBTAINED THEREOF. | |
| ES8801959A1 (en) | Envelope protein of acquired immune deficiency syndrome virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: ONCOGEN |